Halliburton [HAL] vs ChampionX [CHX] Detailed Stock Comparison

Halliburton
NYSE
Loading...

ChampionX
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Halliburton wins in 14 metrics, ChampionX wins in 6 metrics, with 0 ties. Halliburton appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Halliburton | ChampionX | Better |
---|---|---|---|
P/E Ratio (TTM) | 8.33 | 17.09 | Halliburton |
Price-to-Book Ratio | 1.65 | 2.58 | Halliburton |
Debt-to-Equity Ratio | 82.37 | 34.38 | ChampionX |
PEG Ratio | 6.13 | 13.04 | Halliburton |
EV/EBITDA | 5.06 | 6.40 | Halliburton |
Profit Margin (TTM) | 9.31% | 8.20% | Halliburton |
Operating Margin (TTM) | 12.83% | 14.42% | ChampionX |
EBITDA Margin (TTM) | 12.83% | 14.42% | ChampionX |
Return on Equity | 21.00% | 16.83% | Halliburton |
Return on Assets (TTM) | 9.12% | 9.44% | ChampionX |
Free Cash Flow (TTM) | $2.42B | $448.37M | Halliburton |
Dividend Yield | 2.29% | 1.90% | Halliburton |
1-Year Return | -32.12% | -26.45% | ChampionX |
Price-to-Sales Ratio (TTM) | 0.76 | 1.38 | Halliburton |
Enterprise Value | $23.93B | $4.87B | Halliburton |
EV/Revenue Ratio | 1.06 | 1.36 | Halliburton |
Gross Profit Margin (TTM) | 16.23% | 33.72% | ChampionX |
Revenue per Share (TTM) | $26 | $19 | Halliburton |
Earnings per Share (Diluted) | $2.39 | $1.51 | Halliburton |
Beta (Stock Volatility) | 1.20 | 1.51 | Halliburton |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Halliburton vs ChampionX Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Halliburton | -3.57% | -3.79% | 1.84% | 8.38% | -15.33% | -22.11% |
ChampionX | 0.00% | -3.04% | -2.23% | 4.54% | -11.46% | -5.46% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Halliburton | -32.12% | -22.27% | 45.06% | -45.67% | -30.14% | -26.05% |
ChampionX | -26.45% | 32.97% | 166.63% | -32.08% | -32.08% | -32.08% |
Performance & Financial Health Analysis: Halliburton vs ChampionX
Metric | HAL | CHX |
---|---|---|
Market Information | ||
Market Cap | $17.12B | $4.94B |
Market Cap Category | Large cap | Mid cap |
10 Day Avg. Volume | 11,525,830 | 2,539,777 |
90 Day Avg. Volume | 13,994,583 | 2,969,606 |
Last Close | $21.60 | $25.81 |
52 Week Range | $18.72 - $34.62 | $21.92 - $35.94 |
% from 52W High | -37.61% | -28.19% |
All-Time High | $74.33 (Jul 21, 2014) | $46.11 (May 21, 2018) |
% from All-Time High | -70.94% | -44.03% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.07% | -0.06% |
Quarterly Earnings Growth | -0.66% | -0.24% |
Financial Health | ||
Profit Margin (TTM) | 0.09% | 0.08% |
Operating Margin (TTM) | 0.13% | 0.14% |
Return on Equity (TTM) | 0.21% | 0.17% |
Debt to Equity (MRQ) | 82.37 | 34.38 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $12.04 | $10.01 |
Cash per Share (MRQ) | $2.10 | $2.75 |
Operating Cash Flow (TTM) | $3.76B | $482.98M |
Levered Free Cash Flow (TTM) | $1.77B | $252.59M |
Dividends | ||
Last 12-Month Dividend Yield | 2.29% | 1.90% |
Last 12-Month Dividend | $0.51 | $0.50 |
Valuation & Enterprise Metrics Analysis: Halliburton vs ChampionX
Metric | HAL | CHX |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 8.33 | 17.09 |
Forward P/E | 6.13 | 13.04 |
PEG Ratio | 6.13 | 13.04 |
Price to Sales (TTM) | 0.76 | 1.38 |
Price to Book (MRQ) | 1.65 | 2.58 |
Market Capitalization | ||
Market Capitalization | $17.12B | $4.94B |
Enterprise Value | $23.93B | $4.87B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.06 | 1.36 |
Enterprise to EBITDA | 5.06 | 6.40 |
Risk & Other Metrics | ||
Beta | 1.20 | 1.51 |
Book Value per Share (MRQ) | $12.04 | $10.01 |
Financial Statements Comparison: Halliburton vs ChampionX
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | HAL | CHX |
---|---|---|
Revenue/Sales | $5.61B | $864.46M |
Cost of Goods Sold | $4.58B | $572.94M |
Gross Profit | $1.03B | $291.53M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $932.00M | $114.48M |
EBITDA | $1.19B | $179.17M |
Pre-Tax Income | $793.00M | $104.41M |
Income Tax | $179.00M | $15.38M |
Net Income (Profit) | $614.00M | $89.03M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | HAL | CHX |
---|---|---|
Cash & Equivalents | $2.62B | $526.56M |
Total Current Assets | $12.38B | $1.77B |
Total Current Liabilities | $6.05B | $784.90M |
Long-Term Debt | $7.96B | $633.17M |
Total Shareholders Equity | $10.55B | $1.90B |
Retained Earnings | $14.33B | $-171.24M |
Property, Plant & Equipment | $1.02B | $1.54B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | HAL | CHX |
---|---|---|
Operating Cash Flow | $1.31B | $63.44M |
Capital Expenditures | $74.00M | $3.00M |
Free Cash Flow | $1.03B | $35.55M |
Debt Repayment | $-100.00M | $-5.38M |
Common Stock Repurchase | $-309.00M | $0 |
Short Interest & Institutional Ownership Analysis
Metric | HAL | CHX |
---|---|---|
Shares Short | 23.42M | 4.50M |
Short Ratio | 1.55 | 1.56 |
Short % of Float | 0.04% | 0.03% |
Average Daily Volume (10 Day) | 11,525,830 | 2,539,777 |
Average Daily Volume (90 Day) | 13,994,583 | 2,969,606 |
Shares Outstanding | 868.00M | 190.70M |
Float Shares | 854.17M | 189.36M |
% Held by Insiders | 0.01% | 0.01% |
% Held by Institutions | 0.86% | 0.96% |
Dividend Analysis & Yield Comparison: Halliburton vs ChampionX
Metric | HAL | CHX |
---|---|---|
Last 12-Month Dividend | $0.51 | $0.50 |
Last 12-Month Dividend Yield | 2.29% | 1.90% |
3-Year Avg Annual Dividend | $0.52 | $0.39 |
3-Year Avg Dividend Yield | 0.49% | 0.31% |
3-Year Total Dividends | $1.57 | $1.17 |
Ex-Dividend Date | Mar 05, 2025 | Jul 03, 2025 |